End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.05 CNY | +1.33% | +5.59% | +9.41% |
Apr. 24 | Huahai Pharmaceutical Gets Approval to Market Busulfan Injection | MT |
Apr. 19 | Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.41% | 3.26B | |
+25.70% | 661B | |
+26.74% | 566B | |
-6.51% | 352B | |
+20.38% | 332B | |
+3.16% | 283B | |
+13.49% | 231B | |
+4.72% | 200B | |
-9.45% | 195B | |
-5.14% | 145B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Correction: Huahai Pharmaceutical Gets Nod to Amend Specifications for Irbesartan Tablets